Expression of the (Recombinant) Endogenous Immunoglobulin Heavy-Chain Locus Requires the Intronic Matrix Attachment Regions

REFERENCES

• Aguilera, R. J., T. J. Hope, and H. Sakano. 1985. Characterization of immunoglobulin enhancer deletions in murine plasmacytomas. EMBO J. 4:3689–3693.
   PubMed Web of Science ®Google Scholar
• Banerji, J., L. Olson, and W. Schaffner. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33:729–740.
   PubMed Web of Science ®Google Scholar
• Bautista, D., and M. J. Shulman. 1993. A hit-and-run system for introducing mutations into the Ig H chain locus of hybridoma cells by homologous recombination. J. Immunol. 151:1950–1958.
   PubMedGoogle Scholar
• Boulikas, T. 1993. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell. Biochem. 52:14–22.
   PubMedGoogle Scholar
• Buzina, A., and M. J. Shulman. 1996. An element in the endogenous IgH locus stimulates gene targeting in hybridoma cells. Nucleic Acids Res. 24:1525–1530.
   PubMedGoogle Scholar
• Chen, J., F. Young, A. Bottaro, V. Stewart, R. K. Smith, and F. W. Alt. 1993. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J. 12:4635–4645.
   PubMedGoogle Scholar
• Cockerill, P. N. 1990. Nuclear matrix attachment occurs in several regions of the IgH locus. Nucleic Acids Res. 18:2643.
   PubMedGoogle Scholar
• Cockerill, P. N., and T. Garrard. 1986. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44:273.
   PubMed Web of Science ®Google Scholar
• Connor, A., C. Collins, L. Jiang, M. McMaster, and M. J. Shulman. 1993. Isolation of new nonsense and frameshift mutations in the immunoglobulin mu heavy chain gene of hybridoma cells. Somatic Cell Mol. Genet. 19:313–320.
   PubMedGoogle Scholar
• Dickinson, L. A., T. Joh, Y. Kohwi, and T. Kohwi-Shigematsu. 1992. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70:631–645.
   PubMed Web of Science ®Google Scholar
• Fiering, S., E. Epner, K. Robinson, Y. Zhuang, A. Telling, M. Hu, D. I. K. Martin, T. Enver, T. J. Ley, and M. Groudine. 1995. Targeted deletion of 5′HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev. 9:2203–2213.
   PubMedGoogle Scholar
• Fiering, S., C. G. Kim, E. E. Epner, and M. G. Groudine. 1993. An “in-out” strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the p-globin locus control region. Proc. Natl. Acad. Sci. USA 90:8469–8473.
   PubMed Web of Science ®Google Scholar
• Forrester, W. C., C. van Genderen, T. Jenuwein, and R. Grosschedl. 1994. Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions. Science 265:1221–1225.
   PubMedGoogle Scholar
• Gillies, S. D., S. L. Morrison, V. T. Oi, and S. Tonegawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33:717–728.
   PubMed Web of Science ®Google Scholar
• Gram, H., G. Zenke, S. Geisse, B. Kleuser, and K. Burki. 1992. High level expression of a human immunoglobulin transgene depends on switch region sequences. Eur. J. Immunol. 22:1185.
   PubMedGoogle Scholar
• Gross-Bellard, M., P. Oudet, and P. Chambon. 1973. Isolation of high-molecular-weight DNA from mammalian cells. Eur. J. Biochem. 36:32–38.
   PubMedGoogle Scholar
• Grosschedl, R., and M. Marx. 1988. Stable propagation of the active transcriptional state of an immunoglobulin mu gene requires continuous enhancer function. Cell 55:645–654.
   PubMedGoogle Scholar
• Herrscher, R. F., M. H. Kaplan, D. L. Lelsz, C. Das, R. Scheuermann, and P. W. Tucker. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 9:3067–3082.
   PubMedGoogle Scholar
• Kadesch, T., P. Zervos, and D. Ruezinsky. 1986. Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. Nucleic Acids Res. 14:8209–8221.
   PubMed Web of Science ®Google Scholar
• Kim, C. G., E. M. Epner, W. C. Forrester, and M. Groudine. 1992. Inacti-vation of the human β-globin gene by targeted insertion into the β-globin locus control region. Genes Dev. 6:928–938.
   PubMed Web of Science ®Google Scholar
• Klein, S., F. Sablitzky, and A. Radbruch. 1984. Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant. EMBO J. 3:2473–2476.
   PubMed Web of Science ®Google Scholar
• Kohler, G., M. J. Potash, H. Lehrach, and M. J. Shulman. 1982. Deletions in immunoglobulin mu chains. EMBO J. 1:555–563.
   PubMedGoogle Scholar
• Kohler, G., and M. J. Shulman. 1980. Immunoglobulin M mutants. Eur. J. Immunol. 10:467–476.
   Google Scholar
• Kowalski, J., and D. T. Denhardt. 1989. Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 pro-myelocytes. Mol. Cell. Biol. 9:1946–1957.
   PubMedGoogle Scholar
• Laemmli, U. K., E. Kas, L. Poljak, and Y. Adachi. 1992. Scaffold-associated regions: cis-acting determinants of chromatin structural loops and functional domains. Curr. Opin. Genet. Dev. 2:275–285.
   PubMedGoogle Scholar
• Lieberson, R., J. Ong, X. Shi, and L. A. Eckhardt. 1995. Immunoglobulin gene transcription ceases upon deletion of a distant enhancer. EMBO J. 14:6229–6238.
   PubMed Web of Science ®Google Scholar
• Linial, M., N. Gunderson, and M. Groudine. 1985. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science 230:1126.
   PubMed Web of Science ®Google Scholar
• Mulligen, R. C., and P. Berg. 1980. Expression of a bacterial gene in mammalian cells. Science 209:1422–1427.
   PubMedGoogle Scholar
• Neuberger, M. S. 1983. Expression and regulation of immunoglobulin heavy chain genes transfected into lymphoid cells. EMBO J. 2:1373–1378.
   PubMed Web of Science ®Google Scholar
• Oancea, A. E., and M. J. Shulman. 1994. An improved system of somatic cell molecular genetics for analyzing the requirements of Ig synthesis and function. Int. Immunol. 6:1161–1168.
   PubMedGoogle Scholar
• Oancea, A. E., F. W. L. Tsui, and M. J. Shulman. 1995. Targeted removal of the mu switch region from mouse hybridoma cells: a test of its role in gene expression in the endogenous IgH locus. J. Immunol. 155:5678–5683.
   PubMedGoogle Scholar
• Olson, E. N., H. H. Arnold, P. W. J. Rigby, and B. J. Wold. 1996. Know your neighbors: three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85:1–4.
   PubMed Web of Science ®Google Scholar
• Pham, C. T. N., D. M. MacIvor, B. A. Hug, J. W. Heusel, and T. J. Ley. 1996. Long-range disruption of gene expression by a selectable marker cassette. Proc. Natl. Acad. Sci. USA 93:13090–13095.
   PubMedGoogle Scholar
• Pommier, Y., P. N. Cockerill, K. W. Kohn, and W. T. Garrard. 1990. Identification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sites. J. Virol. 64:419–423.
   PubMedGoogle Scholar
• Porton, B., D. M. Zaller, R. Lieberson, and L. A. Eckhardt. 1990. Immunoglobulin heavy-chain enhancer is required to maintain transfected γ2A gene expression in a pre-B-cell line. Mol. Cell. Biol. 10:1076–1083.
   PubMedGoogle Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Scheuermann, R. H., and U. Chen. 1989. A developmental-specific factor binds to suppressor sites flanking the immunoglobulin heavy-chain enhancer. Genes Dev. 3:1255–1266.
   PubMedGoogle Scholar
• Shulman, M. J., C. Heusser, C. Filkin, and G. Kohler. 1982. Mutations affecting the structure and function of immunoglobulin M. Mol. Cell. Biol. 2:1033–1043.
   PubMedGoogle Scholar
• Shulman, M. J., L. Nissen, and C. Collins. 1990. Homologous recombination in hybridoma cells: dependence on time and fragment length. Mol. Cell. Biol. 10:4466–4472.
   PubMed Web of Science ®Google Scholar
• Sigurdardottir, D., J. Sohn, J. Kass, and E. Selsing. 1995. Regulatory regions 3′ of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells. J. Immunol. 154:2217–2225.
   PubMedGoogle Scholar
• Su, L., and T. Kadesch. 1990. The immunoglobulin heavy-chain enhancer functions as the promoter for Iµ, sterile transcription. Mol. Cell. Biol. 10:2619–2624.
   PubMed Web of Science ®Google Scholar
• Sun, W., J. Xiong, and M. Shulman. 1994. Production Of mouse V/human C chimeric κ genes by homologous recombination in hybridoma cells. J. Immunol. 152:695–704.
   PubMedGoogle Scholar
• Wabl, M. R., and P. D. Burrows. 1984. Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer in cis. Proc. Natl. Acad. Sci. USA 81:2452–2455.
   PubMedGoogle Scholar
• Wasylyk, C., and B. Wasylyk. 1986. The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells. EMBO J. 5:553–560.
   PubMed Web of Science ®Google Scholar
• Zaller, D. M., and L. A. Eckhardt. 1985. Deletion of a B-cell specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression. Proc. Natl. Acad. Sci. USA 82:5088–5092.
   PubMed Web of Science ®Google Scholar
• Zong, R.-T., and R. H. Scheuermann. 1995. Mutually exclusive interaction of a novel matrix attachment region binding protein and the NF-µNR enhancer repressor. J. Biol. Chem. 270:24010–24018.
   PubMedGoogle Scholar